![logo](/logos/DMP.DE.webp)
Dermapharm Holding SE
FSX:DMP.DE
32.45 (EUR) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Dermapharm Holding SE |
Symbool | DMP.DE |
Munteenheid | EUR |
Prijs | 32.45 |
Beurswaarde | 1,747,108,000 |
Dividendpercentage | 2.88% |
52-weken bereik | 30.8 - 44.7 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Hans-Georg Feldmeier |
Website | https://www.dermapharm.de |
An error occurred while fetching data.
Over Dermapharm Holding SE
Dermapharm Holding SE, together with its subsidiaries, engages in the off-patent branded pharmaceuticals business in Germany and internationally. It operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. The company develops, manufactures, licenses, markets, and sells branded generics, over-the-counter drugs, non-prescription natural remedies,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (EUR)
Cijfers zijn in miljoenen (EUR)